HealthTrust commits to buying Infraredx coronary imaging tech

Fierce 15 member Infraredx, a diagnostics company specializing in coronary artery disease, has made a deal with HealthTrust, a group purchasing organization. Through the purchasing agreement Infraredx's TVC Imaging System, a dual-modality intravascular imaging technology, will be offered to HealthTrust's member network of 1,400 acute care facilities.The TVC Imaging System provides real-time information to cardiologists about vessel structure and composition structure, as well as lipid core plaques that are known to cause stenting complications. Release

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.